FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Egbert Kruithof

Research Profile

Chemicals & Drugs

Physiology

Fibrinolysis

Anatomy

Co-author Network

Publications

TOP 3
Nathalie Satta; Egbert Kruithof; Céline Fickentscher; Sylvie Dunoyer-Geindre; Françoise Boehlen; Guido Reber; Danielle Burger; Philippe de Moerloose
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.
Egbert Kruithof
Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins.
Nathalie Satta; Egbert Kruithof; Guido Reber; Philippe de Moerloose
Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Egbert Kruithof (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Nathalie Satta; Egbert Kruithof; Céline Fickentscher; Sylvie Dunoyer-Geindre; Françoise Boehlen; Guido Reber; Danielle Burger; Philippe de Moerloose
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.
Blood 2011;117(20):5523-31.
2008: Egbert Kruithof
Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins.
Thrombosis and haemostasis 2008;100(6):969-75.
2008: Nathalie Satta; Egbert Kruithof; Guido Reber; Philippe de Moerloose
Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides.
Molecular immunology 2008;46(1):145-57.
2008: K Hultman; A Tjärnlund-Wolf; R J Fish; U Wilhelmsson; Bertil Rydenhag; M Pekny; Egbert Kruithof; Christina Jern
Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1796-803.
2007: Richard J Fish; Hong Yang; Christelle Viglino; Raoul Schorer; Sylvie Dunoyer-Geindre; Egbert Kruithof
Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues.
The Biochemical journal 2007;405(3):597-604.
2007: J W Liu; Sylvie Dunoyer-Geindre; V Serre-Beinier; G Mai; J-F Lambert; Richard J Fish; Gilles Pernod; L Buehler; Henri Bounameaux; Egbert Kruithof
Characterization of endothelial-like cells derived from human mesenchymal stem cells.
Journal of thrombosis and haemostasis : JTH 2007;5(4):826-34.
2007: Nathalie Satta; Sylvie Dunoyer-Geindre; Guido Reber; Richard J Fish; Françoise Boehlen; Egbert Kruithof; Philippe de Moerloose
The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies.
Blood 2007;109(4):1507-14.
2007: Egbert Kruithof; Nathalie Satta; Jia Wei Liu; Sylvie Dunoyer-Geindre; Richard J Fish
Gene conversion limits divergence of mammalian TLR1 and TLR6.
BMC evolutionary biology 2007;7():148.
2007: Sylvie Dunoyer-Geindre; Brenda R Kwak; Graziano Pelli; Isabelle Roth; Nathalie Satta; Richard J Fish; Guido Reber; François Mach; Egbert Kruithof; Philippe de Moerloose
Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques.
Thrombosis and haemostasis 2007;97(1):129-38.
2006: Richard J Fish; Egbert Kruithof
Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis.
Experimental cell research 2006;312(3):350-61.
2006: Jia Wei Liu; Gilles Pernod; Sylvie Dunoyer-Geindre; Richard J Fish; Hong Yang; Henri Bounameaux; Egbert Kruithof
Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells.
Stem cells (Dayton, Ohio) 2006;24(1):199-208.
2005: Sylvie Dunoyer-Geindre; Yordanka Dimitrova; Richard J Fish; Nathalie Satta; Guido Reber; Egbert Kruithof; Philippe de Moerloose
Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies.
Thrombosis and haemostasis 2005;93(2):339-45.
2004: Egbert Kruithof; Wolf-Dieter Schleuning
A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
Thrombosis and haemostasis 2004;92(3):559-67.
2004: Richard J Fish; Egbert Kruithof
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
BMC molecular biology 2004;5():9.
2004: Sylvie Dunoyer-Geindre; Egbert Kruithof; Françoise Boehlen; N Satta-Poschung; Guido Reber; Philippe de Moerloose
Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1176-81.
2004: Gilles Pernod; Richard J Fish; Jia Wei Liu; Egbert Kruithof
Increasing lentiviral vector titer using inhibitors of protein kinase R.
BioTechniques 2004;36(4):576-8, 580.
2003: Yordanka Dimitrova; Sylvie Dunoyer-Geindre; Guido Reber; François Mach; Egbert Kruithof; Philippe de Moerloose
Effects of statins on adhesion molecule expression in endothelial cells.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2290-9.
2002: Sylvie Dunoyer-Geindre; Philippe de Moerloose; Béatrix Galve-de Rochemonteix; Guido Reber; Egbert Kruithof
NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies.
Thrombosis and haemostasis 2002;88(5):851-7.
2002: Denise Huber; Elisabeth M Cramer; Jocelyne E Kaufmann; Paolo Meda; Jean-Marc Massé; Egbert Kruithof; Ulrich Vischer
Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo.
Blood 2002;99(10):3637-45.
2001: Michael S Pepper; C Rosnoblet; C Di Sanza; Egbert Kruithof
Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Thrombosis and haemostasis 2001;86(2):702-9.
2001: Sylvie Dunoyer-Geindre; Egbert Kruithof; Béatrix Galve-de Rochemonteix; C Rosnoblet; Jean Gruenberg; Guido Reber; Philippe de Moerloose
Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells.
Thrombosis and haemostasis 2001;85(5):903-7.
2000: H Bounameaux; Egbert Kruithof
On the association of elevated tPA/PAI-1 complex and von Willebrand factor with recurrent myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(8):1857-9.
2000: Tetsuyuki Kobayashi; Ulrich Vischer; C Rosnoblet; Cecile Lebrand; Margaret Lindsay; Robert Parton; Egbert Kruithof; Jean Gruenberg
The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells.
Molecular biology of the cell 2000;11(5):1829-43.
2000: C Camani; O Gavin; Egbert Kruithof
Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Thrombosis and haemostasis 2000;83(2):290-6.
2000: Béatrix Galve-de Rochemonteix; Tetsuyuki Kobayashi; C Rosnoblet; Margaret Lindsay; Robert Parton; Guido Reber; Emmanuel de Maistre; Denis Wahl; Egbert Kruithof; Jean Gruenberg; Philippe de Moerloose
Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):563-74.
2000: C Rosnoblet; A S Ribba; CB Wollheim; Egbert Kruithof; Ulrich Vischer
Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell line.
Biochimica et biophysica acta 2000;1495(1):112-9.
1999: Cristina Lupu; Egbert Kruithof; Vijay V Kakkar; Florea Lupu
Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
Thrombosis and haemostasis 1999;82(6):1652-8.
1999: C Rosnoblet; Ulrich Vischer; R D Gerard; Jean-Claude Irminger; Philippe A Halban; Egbert Kruithof
Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1796-803.
1999: A Scherrer; Annelise WOHLWEND; Egbert Kruithof; Jean-Dominique Vassalli; André-Pascal Sappino
Plasminogen activation in human acute leukaemias.
British journal of haematology 1999;105(4):920-7.
1998: C Camani; O Gavin; C Bertossa; E Samatani; Egbert Kruithof
Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
European journal of biochemistry / FEBS 1998;251(3):804-11.
1997: CL Duboscq; Irene Quintana; E Bassilotta; G E Bergonzelli; P Porterie; Beatriz Sassetti; A S Haedo; N Wainsztein; Egbert Kruithof; Lucía C Kordich
Plasminogen: an important hemostatic parameter in septic patients.
Thrombosis and haemostasis 1997;77(6):1090-5.
1997: Egbert Kruithof; JC Mestries; M P Gascon; A Ythier
The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Thrombosis and haemostasis 1997;77(5):905-10.
1997: J J Mermod; Egbert Kruithof; Sami Alouani; A L Quiquerez; Rémy Sadoul
ApoE genotype does not affect plasma tPA and PAI-1 antigen levels.
American journal of medical genetics 1997;74(2):172-5.
1997: Y Christen; R Wütschert; D Weimer; P de Moerloose; Egbert Kruithof; Henri Bounameaux
Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1997;8(3):185-90.
1997: Lars Reiter; Olivier Spertini; Egbert Kruithof
Plasminogen activators play an essential role in extracellular-matrix invasion by lymphoblastic T cells.
International journal of cancer. Journal international du cancer 1997;70(4):461-6.
1997: Ulrich Vischer; Jørgen Ingerslev; CB Wollheim; JC Mestries; D A Tsakiris; W E Haefeli; Egbert Kruithof
Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
Thrombosis and haemostasis 1997;77(2):387-93.
1997: Ann-Pascale J J Bijnens; I Knockaert; E Cousin; Egbert Kruithof; Paul J Declerck
Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
Thrombosis and haemostasis 1997;77(2):350-6.
1997: Egbert Kruithof; D Agay; JC Mestries; M P Gascon; A Ythier
The effect of factor Xa/phospholipid infusion on the acute phase response in baboons.
Thrombosis and haemostasis 1997;77(2):308-11.
1996: C Trân-Thang; Egbert Kruithof; Harald Lahm; W A Schuster; M Tada; Bernard Sordat
Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells.
British journal of cancer 1996;74(6):846-52.
1996: David J Margolis; Egbert Kruithof; M Barnard; Kenneth Howe; GERALD LAZARUS
Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease.
Journal of the American Academy of Dermatology 1996;34(2 Pt 1):204-8.
1995: Egbert Kruithof; Mark Baker; C L Bunn
Biological and clinical aspects of plasminogen activator inhibitor type 2.
Blood 1995;86(11):4007-24.
1995: C Camani; Egbert Kruithof
The role of the finger and growth factor domains in the clearance of tissue-type plasminogen activator by hepatocytes.
The Journal of biological chemistry 1995;270(44):26053-6.
1995: Peter Bärtsch; B Welsch; M Albert; Birgit Friedmann; M Levi; Egbert Kruithof
Balanced activation of coagulation and fibrinolysis after a 2-h triathlon.
Medicine and science in sports and exercise 1995;27(11):1465-70.
1995: Florea Lupu; D A Heim; Fedor Bachmann; M Hurni; Vijay V Kakkar; Egbert Kruithof
Plasminogen activator expression in human atherosclerotic lesions.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1444-55.
1994: C Tran-Thang; D Vouillamoz; Egbert Kruithof; Bernard Sordat
Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
Journal of cellular physiology 1994;161(2):285-92.
1994: Florea Lupu; D Heim; Fedor Bachmann; Egbert Kruithof
Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1438-44.
1994: C Camani; Egbert Kruithof
Clearance receptors for tissue-type plasminogen activator.
International journal of hematology 1994;60(2):97-109.
1994: J C Mestries; Egbert Kruithof; M P Gascon; Francis Herodin; D Agay; A Ythier
In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.
European cytokine network 1994;5(3):275-81.
1994: C Camani; Fedor Bachmann; Egbert Kruithof
The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cells.
The Journal of biological chemistry 1994;269(8):5770-5.
1993: Walter E Laug; X R Cao; Y B Yu; Hiroyuki Shimada; Egbert Kruithof
Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.
Cancer research 1993;53(24):6051-7.
1993: W A Schuster; Robert L Medcalf; Egbert Kruithof
Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Endocrinology 1993;133(4):1724-30.
1993: Mojca Stegnar; A Zore; Z Novak-Antolic; N Vovk; Egbert Kruithof
Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Thrombosis and haemostasis 1993;70(3):486-90.
1993: E Pujade-Lauraine; H Lu; Shahsultan Mirshahi; Jeannette Soria; Claudine Soria; A Bernadou; Egbert Kruithof; H R Lijnen; P Burtin
The plasminogen-activation system in ovarian tumors.
International journal of cancer. Journal international du cancer 1993;55(1):27-31.
1993: Florea Lupu; G E Bergonzelli; D A Heim; E Cousin; C Y Genton; Fedor Bachmann; Egbert Kruithof
Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(7):1090-100.
1993: G Nguyen; Egbert Kruithof
A quantitative receptor assay using Triton X-114 for plasminogen activator binding proteins in solubilized membranes from human liver and placenta.
Analytical biochemistry 1993;208(2):277-82.
1993: Lars Reiter; Egbert Kruithof; J F Cajot; Bernard Sordat
The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.
International journal of cancer. Journal international du cancer 1993;53(3):444-50.
1992: G Nguyen; S J Self; C Camani; Egbert Kruithof
Characterization of the binding of plasminogen activators to plasma membranes from human liver.
The Biochemical journal 1992;287 ( Pt 3)():911-5.
1992: Walter E Laug; K Wang; R Mundi; W Rideout; Egbert Kruithof; E Bogenmann
Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells.
International journal of cancer. Journal international du cancer 1992;52(2):298-304.
1992: G E Bergonzelli; Egbert Kruithof; Robert L Medcalf
Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate.
Endocrinology 1992;131(3):1467-72.
1992: V Grimaudo; Fedor Bachmann; J Hauert; M A Christe; Egbert Kruithof
Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
Thrombosis and haemostasis 1992;67(4):397-401.
1992: G Nguyen; S J Self; C Camani; Egbert Kruithof
Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells.
The Journal of biological chemistry 1992;267(9):6249-56.
1991: H J Rapold; V Grimaudo; P J Declerck; Egbert Kruithof; Fedor Bachmann
Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase.
Blood 1991;78(6):1490-5.
1991: G E Bergonzelli; Egbert Kruithof
Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
Thrombosis and haemostasis 1991;66(2):222-5.
1991: G E Bergonzelli; Egbert Kruithof
Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Journal of cellular physiology 1991;148(2):306-13.
1991: E Cousin; Robert L Medcalf; G E Bergonzelli; Egbert Kruithof
Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter.
Nucleic acids research 1991;19(14):3881-6.
1991: A Scherrer; Egbert Kruithof; J P Grob
Plasminogen activator inhibitor-2 in patients with monocytic leukemia.
Leukemia 1991;5(6):479-86.
1991: J Diéval; G Nguyen; S Gross; J Delobel; Egbert Kruithof
A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1.
Blood 1991;77(3):528-32.
1990: P J Grant; Egbert Kruithof; C P Felley; J P Felber; Fedor Bachmann
Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man.
Clinical science (London, England : 1979) 1990;79(5):513-6.
1990: J F Cajot; J Bamat; G E Bergonzelli; Egbert Kruithof; Robert L Medcalf; J Testuz; Bernard Sordat
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):6939-43.
1990: Eric Rondeau; Béatrice Mougenot; Roger Lacave; Marie-Noëlle Peraldi; Egbert Kruithof; Jean-Daniel Sraer
Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies.
Clinical nephrology 1990;33(2):55-60.
1990: V Grimaudo; Fedor Bachmann; Egbert Kruithof
Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.
Haemostasis 1990;20(6):329-33.
1989: Dominique Belin; Annelise WOHLWEND; W D Schleuning; Egbert Kruithof; Jean-Dominique Vassalli
Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2.
The EMBO journal 1989;8(11):3287-94.
1989: C Tran-Thang; J Fasel-Felley; G Pralong; J R Hofstetter; Fedor Bachmann; Egbert Kruithof
Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Thrombosis and haemostasis 1989;62(2):651-3.
1989: G Pralong; T Calandra; M P Glauser; J Schellekens; J Verhoef; Fedor Bachmann; Egbert Kruithof
Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.
Thrombosis and haemostasis 1989;61(3):459-62.
1989: Peter Bärtsch; André Haeberli; M Franciolli; Egbert Kruithof; P W Straub
Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;66(5):2136-44.
1989: V Grimaudo; F Gueissaz; J Hauert; A Sarraj; Egbert Kruithof; Fedor Bachmann
Necrosis of skin induced by coumarin in a patient deficient in protein S.
BMJ (Clinical research ed.) 1989;298(6668):233-4.
1988: Egbert Kruithof; E Cousin
Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene.
Biochemical and biophysical research communications 1988;156(1):383-8.
1988: Robert L Medcalf; Egbert Kruithof; W D Schleuning
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.
The Journal of experimental medicine 1988;168(2):751-9.
1988: G Nguyen; M H Horellou; Egbert Kruithof; J Conard; M M Samama
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
Blood 1988;72(2):601-5.
1988: V Grimaudo; J Hauert; Fedor Bachmann; Egbert Kruithof
Diurnal variation of the fibrinolytic system.
Thrombosis and haemostasis 1988;59(3):495-9.
1988: V Grimaudo; abdel Omri; Egbert Kruithof; J Hauert; Fedor Bachmann
Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
Thrombosis and haemostasis 1988;59(3):388-91.
1988: abdel Omri; Egbert Kruithof; Fedor Bachmann
Histidine-rich glycoprotein during pregnancy.
Thrombosis and haemostasis 1988;59(2):341.
1988: G Nicoloso; J Hauert; Egbert Kruithof; G Van Melle; Fedor Bachmann
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Thrombosis and haemostasis 1988;59(2):299-303.
1988: U Kiso; H Kaudewitz; A Henschen; B Astedt; Egbert Kruithof; Fedor Bachmann
Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinases.
FEBS letters 1988;230(1-2):51-6.
1988: Egbert Kruithof; A Gudinchet; Fedor Bachmann
Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
Thrombosis and haemostasis 1988;59(1):7-12.
1988: G Nicoloso; J Hauert; Egbert Kruithof; G van Melle; Fedor Bachmann
[Differentiation of a normal population and of a cohort of patients presenting with a history of idiopathic thromboembolism as identified with fibrinolytic tests].
Schweizerische medizinische Wochenschrift 1988;118(4):122-4.
1988: Paul J Declerck; M C Alessi; M Verstreken; Egbert Kruithof; I Juhan-Vague; Désiré Collen
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.
Blood 1988;71(1):220-5.
1988: Egbert Kruithof
Plasminogen activator inhibitors--a review.
Enzyme 1988;40(2-3):113-21.
1987: Irène Juhan-Vague; Marie-Christine Alessi; C Fossat; P J Declerck; Egbert Kruithof
Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture.
Thrombosis and haemostasis 1987;58(4):1096.
1987: W D Schleuning; Robert L Medcalf; C Hession; R Rothenbühler; A Shaw; Egbert Kruithof
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells.
Molecular and cellular biology 1987;7(12):4564-7.
1987: Egbert Kruithof; G Nicolosa; Fedor Bachmann
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.
Blood 1987;70(5):1645-53.
1987: J F Cajot; E Bachmann; E Cousin; Egbert Kruithof; W D Schleuning; J Hauert; Fedor Bachmann
Monoclonal antibodies directed against human tissue-type plasminogen activator: a characterization of their species specificity, affinity and heavy-chain binding.
Thrombosis research 1987;46(1):141-52.
1987: C Genton; Egbert Kruithof; W D Schleuning
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
The Journal of cell biology 1987;104(3):705-12.
1987: Egbert Kruithof; C Tran-Thang; A Gudinchet; J Hauert; G Nicoloso; C Genton; H Welti; Fedor Bachmann
Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.
Blood 1987;69(2):460-6.
1986: J F Cajot; Egbert Kruithof; W D Schleuning; Bernard Sordat; Fedor Bachmann
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines.
International journal of cancer. Journal international du cancer 1986;38(5):719-27.
1986: C Tran-Thang; Egbert Kruithof; J Atkinson; Fedor Bachmann
High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin.
European journal of biochemistry / FEBS 1986;160(3):599-604.
1986: J F Cajot; Bernard Sordat; Egbert Kruithof; Fedor Bachmann
Human primary colon carcinomas xenografted into nude mice. I. Characterization of plasminogen activators expressed by primary tumors and their xenografts.
Journal of the National Cancer Institute 1986;77(3):703-12.
1986: Egbert Kruithof; J D Vassalli; W D Schleuning; R J Mattaliano; Fedor Bachmann
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.
The Journal of biological chemistry 1986;261(24):11207-13.
1986: Egbert Kruithof; C Tran-Thang; Fedor Bachmann
Studies on the release of a plasminogen activator inhibitor by human platelets.
Thrombosis and haemostasis 1986;55(2):201-5.
1986: Egbert Kruithof; C Tran-Thang; Fedor Bachmann
The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
Thrombosis and haemostasis 1986;55(1):65-9.
1985: M Stalder; J Hauert; Egbert Kruithof; Fedor Bachmann
Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA.
British journal of haematology 1985;61(1):169-76.
1985: Egbert Kruithof; W D Schleuning; Fedor Bachmann
Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.
The Biochemical journal 1985;226(3):631-6.
1984: C Tran-Thang; Egbert Kruithof; Fedor Bachmann
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
The Journal of clinical investigation 1984;74(6):2009-16.
1984: Egbert Kruithof; C Tran-Thang; A Ransijn; Fedor Bachmann
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.
Blood 1984;64(4):907-13.
1984: C Tran-Thang; Egbert Kruithof; Fedor Bachmann
The mechanism of in vitro clot lysis induced by vascular plasminogen activator.
Blood 1984;63(6):1331-7.
1982: Jean-Daniel Tissot; P Schneider; J Hauert; M Ruegg; Egbert Kruithof; Fedor Bachmann
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
The Journal of clinical investigation 1982;70(6):1320-3.
1982: Egbert Kruithof; A Ransijn; Fedor Bachmann
Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators.
Thrombosis research 1982;28(2):251-60.